| P2093 | author name string | Christian Datz | |
| | Elmar Aigner | |
| | David Niederseer | |
| | Thomas K Felder | |
| P2860 | cites work | A novel mammalian iron-regulated protein involved in intracellular iron metabolism | Q22253435 |
| | Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization | Q24310115 |
| | Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival | Q44712530 |
| | Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver | Q44749296 |
| | Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome | Q45105183 |
| | Iron stores, blood donation, and insulin sensitivity and secretion | Q46564675 |
| | Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease | Q46573527 |
| | Serum ferritin is associated with visceral fat area and subcutaneous fat area | Q46722326 |
| | Diabetes and serum ferritin concentration among U.S. adults | Q46916735 |
| | Association between serum ferritin and the insulin resistance syndrome in a representative population | Q46923446 |
| | Serum ferritin, cardiovascular risk factors and ischaemic heart diseases: a prospective analysis in the SU.VI.MAX (SUpplementation en VItamines et Minéraux AntioXydants) cohort | Q46946265 |
| | Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin | Q47930921 |
| | Transferrin and iron induce insulin resistance of glucose transport in adipocytes. | Q50723407 |
| | Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. | Q50910102 |
| | Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis. | Q51488428 |
| | Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. | Q52549517 |
| | Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. | Q53928507 |
| | Insulin resistance-associated hepatic iron overload. | Q54074092 |
| | Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload | Q56489910 |
| | Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance | Q57659908 |
| | Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) | Q24320295 |
| | A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation | Q28140006 |
| | Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis | Q28188379 |
| | Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH | Q28261861 |
| | The serine protease TMPRSS6 is required to sense iron deficiency | Q28278593 |
| | Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease | Q28291518 |
| | Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse | Q28297185 |
| | Increased oxidative stress in obesity and its impact on metabolic syndrome | Q29012150 |
| | The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 |
| | Balancing acts: molecular control of mammalian iron metabolism | Q29620380 |
| | The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation | Q29620394 |
| | Body iron stores in relation to risk of type 2 diabetes in apparently healthy women | Q34297017 |
| | Insulin resistance and ferritin as major determinants of abnormal serum aminotransferase in severely obese children | Q34695885 |
| | Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease | Q35631734 |
| | Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. | Q35781449 |
| | The iron-heart disease connection: is it dead or just hiding? | Q35824968 |
| | Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations | Q36293397 |
| | Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver | Q36482256 |
| | Hemochromatosis gene and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | Q36727784 |
| | Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload | Q36756528 |
| | Hemochromatosis: an endocrine liver disease. | Q36948509 |
| | Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells | Q37262477 |
| | Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism | Q37269547 |
| | Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study. | Q37328250 |
| | Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target | Q37896246 |
| | The relationship between obesity and hypoferraemia in adults: a systematic review. | Q37943391 |
| | Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis | Q38516501 |
| | Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. | Q40229390 |
| | Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations | Q40342738 |
| | Iron and the sex difference in heart disease risk | Q41531831 |
| | Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells | Q41692331 |
| | Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin | Q42743122 |
| | Iron stores, liver transaminase levels and metabolic risk in healthy teenagers | Q43202057 |
| | Gestational diabetes mellitus in the last trimester - a feature of maternal iron excess? | Q43586066 |
| | Iron chelation improves endothelial function in patients with coronary artery disease. | Q43636907 |
| | Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients | Q43697483 |
| | Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis | Q43712747 |
| | Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function | Q43935417 |
| | Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial | Q44650649 |
| | Serum ferritin concentration predicts mortality in patients awaiting liver transplantation | Q44654114 |
| P433 | issue | 2 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 215-224 | |
| P577 | publication date | 2013-01-07 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | Iron homeostasis in the metabolic syndrome | |
| P478 | volume | 43 | |